Relevance of the T cell receptor for immunotherapy of cancer Eckhart WeidmannMassimo TruccoTheresa L. Whiteside Review Pages: 1 - 14
Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use Theresa L. WhitesideGiorgio Parmiani Review Pages: 15 - 21
Decrease in lymphokine-activated killer sensitivity of a human renal-cell carcinoma cell line after cytokine treatment Masahiro YanaseTaiji TsukamotoYoshiyuki Hashimoto Original Articles Pages: 22 - 26
Characterization and purification of a mycoplasma membrane-derived macrophage-activating factor Steve CaplanRuth GallilyYechezkel Barenholz Original Articles Pages: 27 - 33
Persistent augmentation of natural-killer-and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose P. A. PalmerJ. G. M. ScharenbergR. J. Scheper Original Articles Pages: 34 - 40
Antigen forks: bispecific reagents that inhibit cell growth by binding selected pairs of tumor antigens David B. RingSylvia T. Hsieh-MaJohn Reeder Original Articles Pages: 41 - 48
Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinoma F. W. G. HillV. P. M. G. RuttenW. Den Otter Original Articles Pages: 49 - 52
Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2 Marie-Bénédicte Leger-RavetClaire MathiotDominique Emilie Original Articles Pages: 53 - 58
Differential recovery of polymorphonuclear neutrophils, B and T cell subpopulations in the thymus, bone marrow, spleen and blood of mice following split-dose polychemotherapy James E. TalmadgeJohn D. JacksonGreg A. Perry Original Articles Pages: 59 - 67
Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancer A. M. E. NouriR. HydeR. T. D. Oliver Short Communication Pages: 68 - 70
